Logo medicamento Vatilen

Vatilen®

Palbociclib

Therapeutic action

Cyclin-dependent kinase inhibitor.

Indications

HR-positive, HER2-negative advanced or metastatic breast cancer.

Presentation

21 hard capsules of 75 mg, 100 mg. or 125 mg.